Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Cancer Innovation|January 22, 2026
Global, Population and Genetic Evidence on the Relationships Between Immune-Mediated Inflammatory Disease and Cancer RiskXuesi Dong, Jiaxin Xie, Zilin Luo, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 7, 2018
DNA Methylation of LRRC3B: A Biomarker for Survival of Early-Stage Non-Small Cell Lung Cancer PatientsYichen Guo, Ruyang Zhang, Sipeng Shen, et al.
Clinical Nutrition (Edinburgh, Scotland)|February 25, 2025
Systematic analysis of relationships between serum lipids with all-cause and cause-specific mortality: Evidence from prospective cohort studies of UK Biobank and Women's Health InitiativeDongfang You, Yingdan Tang, Theis Lange, et al.
Ebiomedicine|April 18, 2022
APOLLO: An accurate and independently validated prediction model of lower-grade gliomas overall survival and a comparative study of model performanceJiajin Chen, Sipeng Shen, Yi Li, et al.
Thoracic Cancer|February 9, 2022
Lung cancer risk prediction models based on pulmonary nodules: A systematic reviewZheng Wu, Fei Wang, Wei Cao, et al.
Molecular Oncology|December 21, 2021
Epigenome-wide three-way interaction study identifies a complex pattern between TRIM27, KIAA0226, and smoking associated with overall survival of early-stage NSCLCXinyu Ji, Lijuan Lin, Juanjuan Fan, et al.
International Journal of Molecular Sciences|January 1, 2020
Integrated Transcriptomics, Metabolomics, and Lipidomics Profiling in Rat Lung, Blood, and Serum for Assessment of Laser Printer-Emitted Nanoparticle Inhalation Exposure-Induced Disease RisksNancy Lan Guo, Tuang Yeow Poh, Sandra Pirela, et al.
Molecular Oncology|November 21, 2022
A trans-omics assessment of gene-gene interaction in early-stage NSCLCJiajin Chen, Yunjie Song, Yi Li, et al.
Clinical Epigenetics|April 6, 2018
Epigenetic modifications in KDM lysine demethylases associate with survival of early-stage NSCLCYongyue Wei, Junya Liang, Ruyang Zhang, et al.
Molecular Oncology|April 16, 2018
A multi-omic study reveals BTG2 as a reliable prognostic marker for early-stage non-small cell lung cancerSipeng Shen, Ruyang Zhang, Yichen Guo, et al.
Pageof 8